News & Updates

Show Multimedia Only

Women working in service industry at greater risk for LUTS

24 Feb 2026

A recent study has found that employment in managerial and professional positions across early and mid-adulthood may result in a reduced risk for lower urinary tract symptoms (LUTS) at midlife, while that in service positions tends to increase such risk.

Women working in service industry at greater risk for LUTS

24 Feb 2026

Positive ctDNA predicts metastasis in MIBC after TMT

24 Feb 2026 by

Plasma circulating tumour DNA (ctDNA) can act as a biomarker for the early detection of metastatic progression in patients with muscle-invasive bladder cancer (MIBC) treated with bladder-sparing trimodality therapy (TMT), suggests a study.

Positive ctDNA predicts metastasis in MIBC after TMT

24 Feb 2026

Are platelet-rich therapies the answer to erectile dysfunction?

24 Feb 2026

Platelet-rich therapies (PRTs) do not appear to be better than placebo in improving sexual function in men with erectile dysfunction (ED), a study has shown.

Are platelet-rich therapies the answer to erectile dysfunction?

24 Feb 2026

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

24 Feb 2026 by

A novel therapeutic approach combining behavioural and biologic treatments appears feasible for the management of individuals with Crohn’s disease, based on feasibility and early outcomes from the CATHARSIS* trial.

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

24 Feb 2026

Add-on ipatasertib in maintenance setting a promising strategy in PIK3CA-mutated breast cancer

24 Feb 2026

Adding ipatasertib to dual anti-HER2 maintenance therapy appears to be safe and beneficial to patients with HER2-positive metastatic breast cancer harbouring PIK3CA mutations, according to a phase Ib study.

Add-on ipatasertib in maintenance setting a promising strategy in PIK3CA-mutated breast cancer

24 Feb 2026

Hydroxychloroquine shows potential survival benefit in systemic sclerosis

24 Feb 2026

Systemic sclerosis (SSc) patients using hydroxychloroquine have reduced mortality, although they appear to have a higher prevalence of pulmonary hypertension compared with their peers who do not use the drug, according to a retrospective study.

Hydroxychloroquine shows potential survival benefit in systemic sclerosis

24 Feb 2026

Chronic liver disease ups risk of post-ERCP complications

23 Feb 2026

Endoscopic retrograde cholangiopancreatography (ERCP), although deemed safe, is associated with the highest risk of complications when compared with other endoscopic procedures, reveals a study.

Chronic liver disease ups risk of post-ERCP complications

23 Feb 2026

Rehab helps resolve platypnoea–orthodeoxia syndrome in COVID-19 patients

23 Feb 2026 by

Timely and effective rehabilitation interventions can improve orthodeoxia and functional outcome in patients with COVID-19-related platypnoea‒orthodeoxia syndrome (POS), suggests a Singapore study.

Rehab helps resolve platypnoea–orthodeoxia syndrome in COVID-19 patients

23 Feb 2026

Sexual dysfunction prevalent in breast cancer survivors

23 Feb 2026

Breast cancer survivors often experience female sexual dysfunction (FSD), which is significantly associated with disease-related factors and the lack of sexual counselling, reports a study.

Sexual dysfunction prevalent in breast cancer survivors

23 Feb 2026

Young at gut: How to modulate the microbiome for healthy ageing?

23 Feb 2026 by

At the Microbiome Summit 2026, experts shared insights into how the gut microbiome can be modulated to support healthy ageing.

Young at gut: How to modulate the microbiome for healthy ageing?

23 Feb 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Women working in service industry at greater risk for LUTS

Women working in service industry at greater risk for LUTS

Positive ctDNA predicts metastasis in MIBC after TMT

Positive ctDNA predicts metastasis in MIBC after TMT

Are platelet-rich therapies the answer to erectile dysfunction?

Are platelet-rich therapies the answer to erectile dysfunction?

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

Add-on ipatasertib in maintenance setting a promising strategy in PIK3CA-mutated breast cancer

Add-on ipatasertib in maintenance setting a promising strategy in PIK3CA-mutated breast cancer

Hydroxychloroquine shows potential survival benefit in systemic sclerosis

Hydroxychloroquine shows potential survival benefit in systemic sclerosis

Chronic liver disease ups risk of post-ERCP complications

Chronic liver disease ups risk of post-ERCP complications

Rehab helps resolve platypnoea–orthodeoxia syndrome in COVID-19 patients

Rehab helps resolve platypnoea–orthodeoxia syndrome in COVID-19 patients

Sexual dysfunction prevalent in breast cancer survivors

Sexual dysfunction prevalent in breast cancer survivors

Young at gut: How to modulate the microbiome for healthy ageing?

Young at gut: How to modulate the microbiome for healthy ageing?